- Home
- SLRC vs KURA Comparison
SLRC vs KURA Comparison
Compare SLRC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRC
- KURA
- Stock Information
- Founded
- SLRC 2007
- KURA 2014
- Country
- SLRC United States
- KURA United States
- Employees
- SLRC N/A
- KURA N/A
- Industry
- SLRC Finance/Investors Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLRC Finance
- KURA Health Care
- Exchange
- SLRC Nasdaq
- KURA Nasdaq
- Market Cap
- SLRC 771.9M
- KURA 713.5M
- IPO Year
- SLRC 2010
- KURA N/A
- Fundamental
- Price
- SLRC $15.46
- KURA $10.44
- Analyst Decision
- SLRC Hold
- KURA Strong Buy
- Analyst Count
- SLRC 6
- KURA 13
- Target Price
- SLRC $15.96
- KURA $25.00
- AVG Volume (30 Days)
- SLRC 339.6K
- KURA 2.0M
- Earning Date
- SLRC 11-04-2025
- KURA 11-04-2025
- Dividend Yield
- SLRC 10.72%
- KURA N/A
- EPS Growth
- SLRC N/A
- KURA N/A
- EPS
- SLRC 1.63
- KURA N/A
- Revenue
- SLRC $222,445,000.00
- KURA $83,279,000.00
- Revenue This Year
- SLRC N/A
- KURA $68.63
- Revenue Next Year
- SLRC $0.23
- KURA $141.59
- P/E Ratio
- SLRC $9.51
- KURA N/A
- Revenue Growth
- SLRC N/A
- KURA N/A
- 52 Week Low
- SLRC $13.64
- KURA $5.41
- 52 Week High
- SLRC $17.94
- KURA $19.73
- Technical
- Relative Strength Index (RSI)
- SLRC 59.30
- KURA 60.28
- Support Level
- SLRC $13.95
- KURA $9.08
- Resistance Level
- SLRC $15.59
- KURA $11.06
- Average True Range (ATR)
- SLRC 0.27
- KURA 0.58
- MACD
- SLRC 0.19
- KURA 0.00
- Stochastic Oscillator
- SLRC 90.85
- KURA 71.46
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.